| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/25/2009 | CN101374552A Medicine for transnasal administration |
| 02/25/2009 | CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue |
| 02/25/2009 | CN101374531A Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents |
| 02/25/2009 | CN101374530A Chitosan and heparin nanoparticles |
| 02/25/2009 | CN101374529A Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 02/25/2009 | CN101374528A Therapeutic uses of inhibitors of RTP801 |
| 02/25/2009 | CN101374527A Preparation of pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid |
| 02/25/2009 | CN101374526A Fast acting inhibitor of gastric acid secretion |
| 02/25/2009 | CN101374525A Memantine for the treatment of childhood behavioral disorders |
| 02/25/2009 | CN101374524A Combination of mTOR inhibitor and antipolate compound |
| 02/25/2009 | CN101374523A Dipeptidyl peptidase inhibitors for treating diabetes |
| 02/25/2009 | CN101374522A ANG2 and VEGF inhibitor combinations |
| 02/25/2009 | CN101374521A Tamper resistant dosage forms |
| 02/25/2009 | CN101374520A Remedy for diabetic |
| 02/25/2009 | CN101374519A Modulators of muscarinic receptors |
| 02/25/2009 | CN101374518A Novel histidine derivative |
| 02/25/2009 | CN101374517A Use of 2-imidazoles for the treatment of CNS disorders |
| 02/25/2009 | CN101374516A Use of substituted 2-imidazole of imidazoline derivatives |
| 02/25/2009 | CN101374515A Akt活性抑制剂 Akt activity inhibitor |
| 02/25/2009 | CN101374514A Neuronal nicotinic receptor ligands and their use |
| 02/25/2009 | CN101374513A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy |
| 02/25/2009 | CN101374512A Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| 02/25/2009 | CN101374511A Pharmaceutical formulations of gallium salts |
| 02/25/2009 | CN101374510A Anti-histamine compositions and use thereof |
| 02/25/2009 | CN101374509A Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production |
| 02/25/2009 | CN101374508A Novel nitrocatechol derivatives having selectin ligand activity |
| 02/25/2009 | CN101374507A Stable pharmaceutical formulations containing escitalopram and bupropion |
| 02/25/2009 | CN101374503A Quickly disintegrating tablet produced by direct dry-tabletting |
| 02/25/2009 | CN101374502A Medicament for topical use |
| 02/25/2009 | CN101374501A Composition and method of use thereof |
| 02/25/2009 | CN101374500A Film-shaped drug forms for use in the oral cavity (wafers) |
| 02/25/2009 | CN101374499A Topical mecamylamine formulations for ocular administration and uses thereof |
| 02/25/2009 | CN101374496A Use of a composition containing an ecdysteroid |
| 02/25/2009 | CN101374426A Use of soluble dietary fibres against muscle wasting |
| 02/25/2009 | CN101374416A Method of reversing, preventing, delaying or stabilizing soft tissue calcification |
| 02/25/2009 | CN101374415A Compounds for the treatment of metabolic disorders |
| 02/25/2009 | CN101374414A Compounds for the treatment of metabolic disorders |
| 02/25/2009 | CN101372514A Scaphium scaphigerum polysaccharide, preparation and use thereof |
| 02/25/2009 | CN101372499A Novel medicament having antiinflammatory activity |
| 02/25/2009 | CN101372491A Lignan sauchinone antipode, preparation thereof and liver protection application |
| 02/25/2009 | CN101372490A Penem derivative containing sulfhydryl nitrogen heterocyclic ring and vinyl nitrogen heterocyclic ring |
| 02/25/2009 | CN101372489A Carbapenem derivative containing sulfhydryl pyrrolidine formamide benzyl |
| 02/25/2009 | CN101372488A Novel carbapenem compound |
| 02/25/2009 | CN101372475A Aromatic heterocyclic substituted acardite derivative and use thereof |
| 02/25/2009 | CN101372474A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 02/25/2009 | CN101372471A Novel use of alkyl isourea compound and analogues thereof |
| 02/25/2009 | CN101372459A Zwitterionic compounds and use thereof |
| 02/25/2009 | CN101371917A Brain protein hydrolysate sodium chloride injection and preparation method thereof |
| 02/25/2009 | CN101371914A Chinese medicine health-care brassiere |
| 02/25/2009 | CN101371907A Ultra-high biomass all-around ordered high biological activity immunoincompetence disease Chinese medicine preparation |
| 02/25/2009 | CN101371906A Ultra-high biomass ordered high biological activity multi-polymer Chinese medicine preparation |
| 02/25/2009 | CN101371899A Medicine for treating tympanitis |
| 02/25/2009 | CN101371889A A set of medicament prescription for treating skin tinea and preparation method thereof |
| 02/25/2009 | CN101371885A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371884A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371883A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371874A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371873A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371867A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371866A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371865A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 02/25/2009 | CN101371863A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371862A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371861A High-efficient antiviral medicament composition in chickweed as well as preparation method and use thereof |
| 02/25/2009 | CN101371860A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371859A Pharmaceutical combination for preventing birth-defect and improving memory |
| 02/25/2009 | CN101371857A Composite medicament for inhibiting tumor and preparation method thereof as well as technique field |
| 02/25/2009 | CN101371852A Method for preventing and treating leukoderma of prawn |
| 02/25/2009 | CN101371851A Immunity enhancement use of wintercherry fruit polysaccharide |
| 02/25/2009 | CN101371850A Use of gracillin in medicament for killing ectoparasite of aquatic animal |
| 02/25/2009 | CN101371849A Composition for curing coronary heart disease and preparation thereof |
| 02/25/2009 | CN101371848A Medicament for treating burn and scald |
| 02/25/2009 | CN101371847A Use of pseudo ginsengenin in preparing medicament for resisting platelet aggregation |
| 02/25/2009 | CN101371846A Liquid medicine for curing burn and preparation method thereof |
| 02/25/2009 | CN101371845A Medicament composition for curing mouth ulcer |
| 02/25/2009 | CN101371844A Sticking tablet for curing mouth ulcer using mometasone furoate as active component |
| 02/25/2009 | CN101371843A Use of loxapine and amoxapine for the perparation of a medicament for the treatment of pain |
| 02/25/2009 | CN101371842A Lornoxicam microsphere and preparation method thereof |
| 02/25/2009 | CN101371841A Crystallization type Entecavir formulation as well as preparation method and use thereof |
| 02/25/2009 | CN101371840A Novel use of vinetine and analogue thereof |
| 02/25/2009 | CN101371839A Novel use of bisbenzylisoquinoline alkaloids |
| 02/25/2009 | CN101371838A Novel uses of neferine and analogue thereof |
| 02/25/2009 | CN101371837A Uses of B vitamins nicotinic amide in regulating body weight, blood sugar and insulin sensibility |
| 02/25/2009 | CN101371836A Paroxetine enteric sustained-release composition |
| 02/25/2009 | CN101371835A Medicament composition containing l-rebeprazole and uses thereof |
| 02/25/2009 | CN101371834A Medicament composition containing amlodipine besylate and candesartan cilexetil and medicine box |
| 02/25/2009 | CN101371833A Use of 1-aryl-2(1H)-pyridinone compounds in preparing medicament for curing skin pruritus |
| 02/25/2009 | CN101371832A Medical use of triacetyl andrographolide as proinflammatory cytokine inhibitor |
| 02/25/2009 | CN101371831A Use of Fructus arctii aglycone in medicament for killing ectoparasite of aquatic animal |
| 02/25/2009 | CN101371830A Medicament for inhibiting endothelial cell of cerebral vessels to secrete prostaglandin E2 |
| 02/25/2009 | CN101371829A Composition and preparation thereof for curing ischemic heart disease |
| 02/25/2009 | CN101371828A Hypocrellin liposome preparation and preparation method thereof |
| 02/25/2009 | CN101371827A Resveratrol composition for delaying age |
| 02/25/2009 | CN101371826A Percutaneous absorption patch |
| 02/25/2009 | CN101371825A Oral sticking tablets using fluticasone propionate as active component |
| 02/25/2009 | CN101371824A Oral cavity pasting tablets using Methylprednisolone and derivatives thereof as active components |
| 02/25/2009 | CN101371823A Technique for preparing double-acetyl emodic acid sustained-release capsules |
| 02/25/2009 | CN101371821A Anti-cancer medicine composition containing metabolism-resistance medicament |
| 02/25/2009 | CN101371820A Anticancer sustained-release agent containing methotrexate potentiating agent |
| 02/25/2009 | CN101371710A Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |